男性用人工尿道括約筋市場-世界の産業規模、動向、機会、予測、2018～2028年、タイプ別、エンドユーザー別、地域別、競合

男性用人工尿道括約筋の世界市場は、2022年に2億2,645万米ドルと評価され、2028年までのCAGRは5.39%で、予測期間中に目覚ましい成長を遂げると予測されています。

尿失禁（UI）は、経済的・社会的に大きな影響を及ぼす重大な健康問題です。男性の尿失禁症例の増加は、前立腺炎による失禁、外科的処置に起因する神経や筋肉の損傷、感染症などの泌尿器科的疾患の有病率の増加に起因しており、これらはすべて膀胱機能の障害の一因となっています。潜在的な要因のひとつは、前立腺肥大症として知られる前立腺の肥大であり、これは加齢とともに起こる傾向があります。もう1つの潜在的な誘因は、前立腺の炎症を特徴とする前立腺炎です。さらに、失禁は外科的介入によって引き起こされる神経や筋肉の障害の結果として生じることもあります。

主な市場促進要因

高齢化人口の増加

世界の高齢化の進展に伴い、医療の状況は大きく変化しています。長寿が当たり前になるにつれ、加齢に関連した病状が増加しており、その一つが尿失禁です。世界は人口動態革命を目の当たりにしており、世界人口のかなりの部分が黄金期を迎えています。国連によると、60歳以上の人口は2050年までにほぼ倍増し、2017年の9億6,200万人から推定21億人になると予想されています。この人口動態の大きな変化により、尿失禁を含む加齢に伴う健康問題の治療を必要とする潜在的な患者層がますます拡大しています。尿失禁は、不随意的な尿漏れを特徴とする病態であり、高齢者に多くみられます。加齢は、筋力低下やホルモンバランスの乱れなど、様々な生理的変化をもたらし、尿失禁の原因となります。さらに、前立腺肥大症（BPH）や前立腺炎のような加齢に関連した病状も一般的な原因です。高齢化社会が進むにつれ、これらの疾患の有病率も増加し、効果的な治療オプションが必要となっています。高齢者の生活の質を向上させたいという願望が、男性用人工尿道括約筋市場の成長の大きな原動力となっています。尿失禁は個人の日常生活に多大な影響を及ぼし、社会的孤立、恥ずかしさ、自立心の喪失につながります。高齢者の尊厳と幸福を守ることの重要性を認識する医療提供者は、解決策として男性用人工尿道括約筋を推奨するようになってきています。人口の高齢化に伴い、医療技術の進歩により男性用人工尿道括約筋のデザインと有効性が向上しています。最新の器具は、排尿機能のコントロールが向上し、合併症が少なく、患者の快適性が向上しています。このような技術革新により、自立と生活の質の回復を目指す高齢者にとって、人工尿道括約筋はより魅力的で実行可能な選択肢となっています。高齢化人口の増加に伴い、医療支出も増加しています。政府や民間の医療プロバイダーは、高齢者特有のニーズに対応するため、より多くのリソースを割り当てています。医療のインフラやサービスに対するこのような投資の増加には、男性用人工尿道括約筋のような先進医療技術の導入も含まれ、これらは高齢化する患者のケアの質と全体的な幸福を向上させるために極めて重要です。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 男性用人工尿道括約筋の世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別（バルーンリザーバー付きAUS（3コンポーネント）、スプリング付きAUS（2コンポーネント））
  • エンドユーザー別（病院、クリニック、その他医療センター、学術・研究センター）
  • 地域別
  • 企業別（2022年）
• 製品市場マップ
  • タイプ別
  • エンドユーザー別
  • 地域別

第6章 北米の男性用人工尿道括約筋市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の男性用人工尿道括約筋市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋の男性用人工尿道括約筋市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の男性用人工尿道括約筋市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの男性用人工尿道括約筋市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Boston Scientific Corporation
• Zephyr Surgical Implants
• Affluent Medical
• UroMems
• Rigicon
• ProMinent GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Male Artificial Urinary Sphincter Market has valued at USD 226.45 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.39% through 2028. Urinary Incontinence (UI) represents a significant health concern with substantial economic and societal implications. The increase in cases of male urinary incontinence can be attributed to the growing prevalence of urological ailments, such as prostatitis-induced incontinence, nerve and muscle damage resulting from surgical procedures, and infections, among other factors, all of which contribute to disruptions in bladder function. One potential factor is the enlargement of the prostate gland, a condition known as benign prostate hyperplasia, which tends to occur with age. Another potential trigger is prostatitis, characterized by inflammation of the prostate gland. Furthermore, incontinence can also arise as a consequence of nerve and muscle impairment caused by surgical interventions.

Key Market Drivers

Rising Aging Population

The global healthcare landscape is undergoing a transformative shift as the world witnesses an unprecedented increase in the aging population. As longevity becomes the norm, age-related medical conditions are on the rise, one of which is urinary incontinence. The world is witnessing a demographic revolution, with a substantial portion of the global population entering their golden years. According to the United Nations, the number of people aged 60 and over is expected to nearly double by 2050, from 962 million in 2017 to an estimated 2.1 billion. This significant demographic shift is creating an ever-expanding pool of potential patients in need of treatment for age-related health issues, including urinary incontinence. Urinary incontinence, a condition characterized by the involuntary leakage of urine, is more prevalent among older adults. Aging brings about various physiological changes, such as muscle weakening and hormonal imbalances, which can contribute to urinary incontinence. Additionally, age-related medical conditions like benign prostate hyperplasia (BPH) and prostatitis are common culprits. As the aging population grows, so does the prevalence of these conditions, necessitating effective treatment options. The desire for an improved quality of life among the elderly is a significant driving force behind the growth of the male artificial urinary sphincter market. Urinary incontinence can have a profound impact on an individual's daily life, leading to social isolation, embarrassment, and a loss of independence. Recognizing the importance of preserving the dignity and well-being of older adults, healthcare providers are increasingly recommending male artificial urinary sphincters as a solution. In tandem with the aging population, advancements in medical technology have improved the design and effectiveness of male artificial urinary sphincters. Modern devices offer better control over urinary function, fewer complications, and enhanced patient comfort. These innovations have made these devices a more attractive and viable option for older individuals seeking to regain their independence and quality of life. As the aging population grows, so does healthcare spending. Governments and private healthcare providers are allocating more resources to address the unique needs of older adults. This increased investment in healthcare infrastructure and services includes the adoption of advanced medical technologies, such as male artificial urinary sphincters, which are crucial for improving the quality of care and the overall well-being of aging patients.

Prevalence of Urological Disorders

The global healthcare landscape is witnessing a surge in the prevalence of urological disorders, and this phenomenon is reshaping the landscape of medical technology. One significant beneficiary of this trend is the male artificial urinary sphincter market. Urological disorders encompass a range of conditions affecting the urinary tract and male reproductive organs. These disorders include benign prostate hyperplasia (BPH), prostatitis, and other ailments that can lead to urinary incontinence. The global prevalence of these disorders has been on the rise, primarily due to factors such as aging demographics and changes in lifestyle. As the global population ages, the incidence of urological disorders, particularly those associated with aging, has increased significantly. BPH, a non-cancerous enlargement of the prostate gland, is a prime example. It is estimated that by the age of 60, over 50% of men will experience symptoms of BPH. These conditions often lead to urinary incontinence, which necessitates effective management and treatment options like male artificial urinary sphincters. Urological disorders, when left untreated, can have a profound impact on an individual's quality of life. Frequent urination, discomfort, and urinary incontinence can lead to social isolation, reduced mobility, and emotional distress. As awareness of these quality-of-life issues grows, patients and healthcare providers alike are seeking more advanced and reliable solutions. Male artificial urinary sphincters have emerged as a lifeline for individuals battling urological disorders that result in urinary incontinence. These devices are designed to provide precise control over urinary function, offering patients greater independence and an enhanced quality of life. The rising prevalence of urological disorders has driven increased demand for these innovative solutions. The growth of the male artificial urinary sphincter market is further propelled by continuous advancements in medical technology. Modern devices are more sophisticated, user-friendly, and associated with fewer complications. This encourages both healthcare providers and patients to consider these solutions as a viable option for managing urological disorders. Growing awareness about urological disorders and the available treatment options is another pivotal factor. Patients are now more informed about their conditions, leading to proactive healthcare-seeking behaviors. Healthcare providers, in turn, are better educated about the benefits of male artificial urinary sphincters and are more inclined to recommend them as part of a comprehensive treatment plan.

Advancements in Medical Technology

In an era characterized by relentless innovation, medical technology has become a driving force behind advancements in healthcare. One area where this is particularly evident is in the growth of the global male artificial urinary sphincter market. Advancements in medical technology have revolutionized the way we diagnose, treat, and manage various health conditions. This holds true for the field of urology and the treatment of male urinary incontinence. Modern medical technology is enabling healthcare professionals to provide more effective, minimally invasive, and patient-centric solutions. One of the key factors driving the growth of the male artificial urinary sphincter market is the increased precision and control offered by advanced technologies. These devices have evolved to provide patients with a high degree of control over urinary function. They are equipped with sensors, microprocessors, and customizable settings, allowing users to adjust the device to their specific needs. This level of precision enhances patient outcomes and comfort. Advancements in medical technology have led to male artificial urinary sphincters with improved safety profiles. Modern devices are designed to minimize complications and side effects, making them a safer and more attractive option for both patients and healthcare providers. As these safety features become more pronounced, the market is likely to experience continued growth. Technological advancements have also led to the development of minimally invasive procedures for implanting male artificial urinary sphincters. These procedures are less traumatic for patients, resulting in reduced recovery times and improved overall patient experiences. Minimally invasive approaches have broadened the appeal of these devices and expanded their potential patient base. Technological advancements have also led to the development of minimally invasive procedures for implanting male artificial urinary sphincters. These procedures are less traumatic for patients, resulting in reduced recovery times and improved overall patient experiences. Minimally invasive approaches have broadened the appeal of these devices and expanded their potential patient base. The rise of telemedicine and remote monitoring has further accelerated the adoption of male artificial urinary sphincters. Patients can now consult with healthcare providers, receive device adjustments, and monitor their progress remotely, reducing the need for frequent in-person visits. This convenience factor is making the devices more accessible to a wider range of patients. Modern male artificial urinary sphincters are often designed with a patient-centered approach. Feedback from patients and healthcare professionals informs the design and functionality of these devices, ensuring that they meet the specific needs and preferences of users. This approach not only enhances patient satisfaction but also contributes to the continued growth of the market.

Quality of Life Considerations

Quality of life is a fundamental aspect of well-being, and advancements in healthcare technologies are increasingly focused on improving the lives of individuals affected by various medical conditions. In the realm of urology, male urinary incontinence can significantly compromise one's quality of life. Urinary incontinence is a condition characterized by the involuntary loss of urine, and it can have profound effects on an individual's daily life. Beyond the physical discomfort, the emotional and psychological toll of urinary incontinence can be substantial. Individuals often experience embarrassment, social isolation, a loss of self-esteem, and limitations on their daily activities. Quality of life considerations play a central role in driving the adoption of male artificial urinary sphincters. These devices offer individuals suffering from urinary incontinence a chance to regain their dignity and independence. By providing effective control over urinary function, male artificial urinary sphincters empower users to engage in activities they may have previously avoided, thereby improving their overall quality of life. The psychological well-being of individuals with urinary incontinence is a critical factor in their overall health. Constant worry about accidents, anxiety about social interactions, and the frustration of being unable to engage in once-loved activities can take a toll on mental health. Male artificial urinary sphincters address these concerns by offering a sense of security and control, ultimately contributing to better mental well-being. The social isolation experienced by many individuals with urinary incontinence can lead to feelings of loneliness and depression. Quality of life considerations are driving the use of male artificial urinary sphincters to facilitate social reintegration. These devices enable users to participate in social activities, maintain relationships, and lead more fulfilling lives. Urinary incontinence often disrupts sleep patterns, leading to fatigue and a reduced quality of life. Male artificial urinary sphincters can significantly reduce nighttime awakenings due to urinary urgency, allowing users to enjoy uninterrupted and restful sleep. This improved sleep quality contributes to overall well-being. The restoration of continence through male artificial urinary sphincters can boost self-esteem and confidence levels. When individuals regain control over their bladder, they often experience a sense of accomplishment and empowerment, leading to a more positive self-image and improved quality of life.

Key Market Challenges

High Cost of Treatment

One of the primary challenges facing the male artificial urinary sphincter market is the high cost associated with the treatment. The surgical procedure to implant these devices, along with the device itself, can be expensive. This poses a significant financial burden on patients, especially those without adequate health insurance coverage or access to healthcare resources.

Limited Access to Healthcare

Access to healthcare services varies widely around the world, and not all individuals have equal access to advanced treatments like male artificial urinary sphincters. Rural areas and underserved populations may face challenges in accessing specialized urological care and the necessary surgical procedures.

Inadequate Insurance Coverage

In many regions, insurance coverage for male artificial urinary sphincters may be limited or nonexistent. Patients may be required to bear a substantial portion of the costs themselves, discouraging some from seeking treatment.

Complications and Revision Surgery

While male artificial urinary sphincters are generally safe and effective, complications can occur, such as device malfunction or infection. These complications may necessitate revision surgeries, which can be challenging for patients both in terms of physical recovery and financial costs.

Key Market Trends

Minimally Invasive Procedures

A major trend on the horizon is the increasing adoption of minimally invasive procedures for the implantation of male artificial urinary sphincters. These techniques, often involving smaller incisions and less tissue disruption, offer patients shorter recovery times, reduced post-operative pain, and lower risk of complications. As minimally invasive procedures become more refined and accessible, they are likely to become the preferred approach for implanting these devices.

Enhanced Device Technology

Continual advancements in device technology are expected to drive innovation in the male artificial urinary sphincter market. Manufacturers are focusing on creating devices with improved precision, user-friendliness, and durability. Enhanced sensors, better control mechanisms, and connectivity options for remote monitoring are among the developments on the horizon. These technological enhancements will offer patients more personalized and effective solutions for managing urinary incontinence.

Customization and Personalization

Personalized healthcare is becoming increasingly important, and this trend is extending to the male artificial urinary sphincter market. Devices are being designed with greater flexibility to accommodate individual patient needs. Customization options for pressure settings, fluid volume, and timing of sphincter activation will enable urologists to tailor treatments to the unique requirements of each patient.

Telemedicine Integration

The integration of telemedicine and remote monitoring is expected to become a standard practice in the male artificial urinary sphincter market. Patients will have the ability to consult with healthcare providers, receive device adjustments, and monitor their progress remotely. This trend not only enhances patient convenience but also allows for more proactive and efficient management of urinary incontinence.

Segmental Insights

Type Insights

Based on the category of Type, the segment of Artificial Urinary Sphincters (AUS) featuring a three-component design with a balloon reservoir accounted for the largest market share. This type of AUS, which includes a balloon reservoir, is commonly employed for the treatment of urinary incontinence. The balloon reservoir serves as a storage unit for a fluid (typically saline) used to adjust the cuff surrounding the urethra, controlling the flow of urine.

During the forecast period, the AUS segment with a two-component design incorporating a spring is anticipated to experience the most rapid growth. A notable example is the ZSI 375, developed by Zephyr Surgical Implants in 2008, which is widely used. This particular AUS lacks an abdominal component and comes in a ready-to-implant configuration, reducing the time required for implantation. Additionally, it eliminates the need for surgical procedures in the retroperitoneal space due to the absence of an abdominal component. Furthermore, it allows for post-implantation adjustment of device pressure to achieve the desired continence rate. These advantages are expected to drive increased demand in the near future, resulting in a higher market share in terms of sales.

End-user Insights

the hospitals sector held a dominant position in the male artificial urinary sphincter market. This supremacy can be attributed to the increasing number of surgical procedures and a rising incidence of end-stage renal diseases. For instance, according to data from the CDC, in 2021, approximately 786,000 individuals in the United States underwent treatment for end-stage kidney disease, with roughly 71% undergoing dialysis and 29% receiving kidney transplants.

The segment comprising clinics and other healthcare centers is expected to experience significant growth at a considerable CAGR during the projected period. These clinics are well-equipped with the necessary medical instruments and infrastructure. Ambulatory Surgery Centers (ASCs) are specialized surgical facilities primarily focused on providing emergency or same-day surgical procedures and often linked to larger healthcare systems. ASCs offer a wide array of surgical treatments, including procedures for urinary incontinence (UI) such as sling procedures and artificial urinary sphincter (AUS) implantations, among others.

Additional healthcare facilities and centers encompass specialty surgical clinics, urology clinics, hospital-based clinics, and nonprofit healthcare systems. Furthermore, clinics present more cost-effective alternatives compared to hospitals for urological surgeries. As outpatient facilities, these clinics have lower overhead expenses and do not necessitate overnight stays, resulting in reduced overall costs for patients. They also offer shorter waiting times, adopt a patient-centered approach, and frequently employ specialized teams of urologists, nurses, and staff members who possess extensive experience and expertise in urologic surgeries.

Regional Insights

In 2022, Europe emerged as the dominant force in the market. The presence of advanced healthcare systems in Europe has resulted in increased life expectancy, leading to a growing aging population. Approximately one in five individuals in Europe is aged 65 or older, and this demographic group is more susceptible to urinary incontinence (UI). Additionally, the cost of surgical interventions to address UI is considerably higher for individuals. These factors collectively positioned Europe as the primary contributor to revenue in the artificial urinary sphincter market in 2022, and this trend is expected to persist throughout the forecast period.

The North American market for male artificial urinary sphincters is anticipated to experience substantial growth in the forecast period. This can be attributed to the region's well-established healthcare infrastructure, high prevalence of urological disorders, and a strong focus on technological advancements in medical devices. North America is a prominent market for male artificial urinary sphincters, as it is used to diagnose and treat various urological conditions, including kidney stones, enlarged prostates, bladder tumors, and urinary tract strictures, with advanced procedures such as the implantation of male artificial urinary sphincters.

In the United States, AUS has a long history of success among users. Furthermore, the AMS 800, an AUS device developed by Boston Scientific Corporation, has received approval from the U.S. Food and Drug Administration (FDA), ensuring its safety and effectiveness for users. Additionally, it is covered by insurance companies, making it more affordable and accessible to patients in the region.

Key Market Players

Boston Scientific Corporation

Zephyr Surgical Implants

Affluent Medical

UroMems

Rigicon

ProMinent GmbH

Report Scope:

In this report, the Global Male Artificial Urinary Sphincter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Male Artificial Urinary Sphincter Market, By Type:

• AUS with a balloon reservoir (3-component)
• AUS with a spring (2-component)

Male Artificial Urinary Sphincter Market, By End-user:

• Hospitals
• Clinics & Other Healthcare Centers
• Academic & Research Centers

Male Artificial Urinary Sphincter Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Male Artificial Urinary Sphincter Market.

Available Customizations:

• Global Male Artificial Urinary Sphincter market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Male Artificial Urinary Sphincter Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
  • 5.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Product Market Map
  • 5.3.1. By Type
  • 5.3.2. By End-user
  • 5.3.3. By Region

6. North America Male Artificial Urinary Sphincter Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
  • 6.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Male Artificial Urinary Sphincter Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End-user
  • 6.3.2. Canada Male Artificial Urinary Sphincter Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End-user
  • 6.3.3. Mexico Male Artificial Urinary Sphincter Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End-user

7. Europe Male Artificial Urinary Sphincter Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
  • 7.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Male Artificial Urinary Sphincter Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End-user
  • 7.3.2. United Kingdom Male Artificial Urinary Sphincter Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End-user
  • 7.3.3. France Male Artificial Urinary Sphincter Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End-user
  • 7.3.4. Italy Male Artificial Urinary Sphincter Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End-user
  • 7.3.5. Spain Male Artificial Urinary Sphincter Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End-user

8. Asia-Pacific Male Artificial Urinary Sphincter Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
  • 8.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Male Artificial Urinary Sphincter Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End-user
  • 8.3.2. Japan Male Artificial Urinary Sphincter Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End-user
  • 8.3.3. India Male Artificial Urinary Sphincter Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End-user
  • 8.3.4. Australia Male Artificial Urinary Sphincter Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End-user
  • 8.3.5. South Korea Male Artificial Urinary Sphincter Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End-user

9. South America Male Artificial Urinary Sphincter Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
  • 9.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Male Artificial Urinary Sphincter Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End-user
  • 9.3.2. Argentina Male Artificial Urinary Sphincter Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End-user
  • 9.3.3. Colombia Male Artificial Urinary Sphincter Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End-user

10. Middle East and Africa Male Artificial Urinary Sphincter Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
  • 10.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Male Artificial Urinary Sphincter Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End-user
  • 10.3.2. Saudi Arabia Male Artificial Urinary Sphincter Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End-user
  • 10.3.3. UAE Male Artificial Urinary Sphincter Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End-user
  • 10.3.4. Kuwait Male Artificial Urinary Sphincter Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By End-user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Financials (As Reported)
• 14.5. Key Personnel
• 14.6. SWOT Analysis
  • 14.6.1. Boston Scientific Corporation
  • 14.6.2. Zephyr Surgical Implants
  • 14.6.3. Affluent Medical
  • 14.6.4. UroMems
  • 14.6.5. Rigicon
  • 14.6.6. ProMinent GmbH

15. Strategic Recommendations

16. About Us & Disclaimer